comparemela.com

Latest Breaking News On - Kevin kalinsky - Page 1 : comparemela.com

Dr Kalinsky on Abemaciclib/Fulvestrant in HR+/HER2– Breast Cancer Post–CDK4/6i Progression

Kevin Kalinsky, MD, MS, on abemaciclib plus fulvestrant in HR-positive/HER2-negative advanced breast cancer after progression on a CDK4/6 inhibitor and endocrine therapy.

Kevin-kalinsky
Glenn-family-breast-center
Division-of-medical-oncology
Breast-cancer-research
Department-of-hematology
Winship-cancer-institute-of-emory-university
Emory-university-school-of-medicine
Medical-oncology
Emory-university-school
Rand-glenn-family-chair
Breast-medical-oncology
Winship-cancer-institute

Abemaciclib/Fulvestrant Boosts PFS in HR+/HER2– Breast Cancer Post–CDK4/6i Progression

Abemaciclib/Fulvestrant Boosts PFS in HR+/HER2– Breast Cancer Post–CDK4/6i Progression
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Georgia
United-states
Atlanta
Corrs
Kevin-kalinsky
European-union
Glenn-family-breast-center
Emory-winship-cancer-institute

Dr Kalinsky on Unanswered Questions Regarding Genomic Testing in HR+ Breast Cancer

Dr Kalinsky on Unanswered Questions Regarding Genomic Testing in HR+ Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Kevin-kalinsky
Emory-university-school-of-medicine
Department-of-hematology
Winship-cancer-institute-of-emory-university
Glenn-family-breast-center
Breast-cancer-research
Medical-oncology
Emory-university-school
Breast-medical-oncology
Rand-glenn-family-chair
Winship-cancer-institute
Emory-university

EMERALD: Elacestrant in ER+/HER2- Advanced Breast Cancer

Kevin Kalinsky, MD, MS, gives an overview of recent data from the EMERALD trial investigating elacestrant in patients with ER+/HER2- advanced breast cancer.

Kevin-kalinsky
Breast-cancer
Hr-breast-cancer
Hr-positive-breast-cancer
Breast-cancer-treatment
Esr1
Esr1-mutations
Emerald-study
Emerald-trial
Elacestrant

Testing for ESR1 Mutations in Breast Cancer

Kevin Kalinsky, MD, MS, and Erica L. Mayer, MD, MPH, discuss testing practices for ESR1 mutations in patients with breast cancer.

Erical-mayer
Kevin-kalinsky
Breast-cancer
Hr-breast-cancer
Hr-positive-breast-cancer
Breast-cancer-treatment
Esr1
Esr1-mutations
Biomarker-testing
Esr1-testing
Asco-recommendations

vimarsana © 2020. All Rights Reserved.